| RS1554920854 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal insulin-dependent diabetes mellitus, Neonatal insulin-dependent diabetes mellitus |
| RS1554920985 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal insulin-dependent diabetes mellitus, Neonatal insulin-dependent diabetes mellitus |
| RS1554921759 |
HBG1
|
Health Risk |
Pathogenic |
Hereditary persistence of fetal hemoglobin, Hereditary persistence of fetal hemoglobin |
| RS1554922054 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554922200 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554922434 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554922441 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554922455 |
HBG2
|
Health Risk |
Likely pathogenic |
— |
| RS1554922593 |
TH
|
Health Risk |
Pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554922725 |
TH
|
Health Risk |
Pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923004 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923121 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923218 |
TH
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Autosomal recessive DOPA responsive dystonia |
| RS1554923305 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923317 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923513 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923802 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923810 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923852 |
TH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554923999 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554924035 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS1554924079 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554924142 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554924321 |
TH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554924356 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS1554924357 |
TH
|
Health Risk |
Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1554924412 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554924540 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS1554925904 |
LOC101928008;SBF2
|
Health Risk |
Likely pathogenic |
— |
| RS1554926476 |
ABCC8
|
Health Risk |
Pathogenic |
Type 2 diabetes mellitus, Type 2 diabetes mellitus |
| RS1554926539 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554927050 |
ANO5
|
Health Risk |
Likely pathogenic |
— |
| RS1554927408 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, 11 conditions |
| RS1554928786 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS1554928884 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, Pfeiffer syndrome |
| RS1554928978 |
FGFR2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554929292 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Gnathodiaphyseal dysplasia |
| RS1554929301 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS1554930267 |
ANO5
|
Health Risk |
Pathogenic/Likely pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS1554930314 |
ANO5
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS1554930637 |
FGFR2
|
Health Risk |
Pathogenic |
Beare-Stevenson cutis gyrata syndrome, Beare-Stevenson cutis gyrata syndrome |
| RS1554930679 |
ZEB1
|
Health Risk |
Pathogenic |
— |
| RS1554930790 |
FGFR2
|
Health Risk |
Pathogenic |
FGFR2-related craniosynostosis, FGFR2-related craniosynostosis |
| RS1554931219 |
BDNF
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554933168 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1554933565 |
ABCC8
|
Health Risk |
Pathogenic |
Hyperinsulinemic hypoglycemia, familial |
| RS1554933716 |
ANO5
|
Health Risk |
Pathogenic |
— |
| RS1554933746 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554933751 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS1554933780 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS1554933800 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type B |
| RS1554933929 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type B |
| RS1554934073 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1554934109 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554934193 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS1554934210 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554934212 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554934241 |
SMPD1
|
Health Risk |
Pathogenic |
— |
| RS1554934309 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554934406 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935116 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS1554935136 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935254 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935273 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935285 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935439 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935456 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1554935464 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1554935484 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1554935555 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935600 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935610 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935669 |
SMPD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type A |
| RS1554935746 |
SMPD1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type A |
| RS1554937243 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1554937249 |
EBF3
|
Health Risk |
Pathogenic |
— |
| RS1554937698 |
CDKN1C
|
Health Risk |
Likely pathogenic |
IMAGe syndrome, IMAGe syndrome |
| RS1554937726 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1554937790 |
CDKN1C
|
Health Risk |
Pathogenic |
— |
| RS1554937847 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1554937999 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1554938069 |
CDKN1C
|
Health Risk |
Pathogenic |
— |
| RS1554938087 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1554938194 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1554938197 |
CDKN1C
|
Health Risk |
Pathogenic |
Beckwith-Wiedemann syndrome, Beckwith-Wiedemann syndrome |
| RS1554939072 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS1554939189 |
WT1
|
Health Risk |
Likely pathogenic |
— |
| RS1554939785 |
WT1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 4 |
| RS1554939839 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |
| RS1554940316 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Usher syndrome type 1D |
| RS1554940478 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554941241 |
SOX6
|
Health Risk |
Pathogenic |
Tolchin-Le Caignec syndrome, Tolchin-Le Caignec syndrome |
| RS1554943158 |
DEAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 24 |
| RS1554943492 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS1554943789 |
COL13A1
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 19, Congenital myasthenic syndrome 19 |
| RS1554944271 |
DEAF1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 24 |
| RS1554944527 |
DEAF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554944856 |
RAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS1554944877 |
RAG1
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency with skin granulomas, Severe combined immunodeficiency |
| RS1554945031 |
WT1
|
Health Risk |
Pathogenic |
Drash syndrome, Frasier syndrome |